Brent Saunders

CEO, Allergan

Saunders has significant healthcare industry expertise, and is a previous CEO of Bausch + Lomb, he has also held a number of leadership positions at Schering-Plough and was named head of integration for the company’s merger with Merck & Co. Saunders’ dealmaking is the stuff of legend: he then went on to lead Actavis’ takeover of Allergan, and as CEO of the new entity (dubbed Allergan), Saunders was about to pull off the world’s largest-ever inversion deal: Dublin-based Allergan buying the much larger, New York-based Pfizer, but that deal is now off – as the US government changed the tax laws on inversions.

Part of the Power List 2016

Welcome to The Power List 2016 – our second foray into the Top 100 most influential people in the world of ophthalmology.

Though we realize our list can (and should) never be definitive, who can argue that the faces within – both familiar and new – do not beautifully highlight the brilliance and diversity found within the field?

Here, we celebrate 100 reasons to be proud of ophthalmology.

Go to The Power List 2016